Abstract

“A CLINICAL STUDY OF TRIPHALADI GHANA VATI ON DYSLIPIDEMIA”

*Dr. Pankaj Kothari, Mahendra Singh Meena Dr. Hemraj Meena, Dr. Harikrishna BN

Abstract

Objectives: The present study was designed to estimate the efficacy of Triphaladi Ghana Vati in Dyslipidemia. In Ayurveda Dyslipidemia is known as Medoroga. Meda is the main Dushya (Predisposing Factor) and Kapha is the main Dosha (Etiological Factor) of Dyslipidemia. It‟s a Dushya dominant disease Therefore, it was expected that proposed drug check the pathogenesis of Medoroga due to its Medoher properties. Methods: For the clinical trial Patients (n-46) has been selected from the OPD & IPD Arogyashala of National Institute of Ayurveda & Seth Surajmal Bombaiwala Hospital, Jaipur. Orally Triphaladi Ghana Vati 500mg twice a day before meal with lukewarm water were administrate in to patients for 60 days. Regular follow-up of 15 days along with Pathya & Apathya were advised to the Patients. Results: Observation & results obtained were computed statistically and various conclusions were drawn. The mean percentage difference between before and after treatment of serum cholesterol, serum triglyceride, HDL, LDL, VLDL, were respectively 36.59%, 27.67%, 8.71%, 25.13%, 13.45.%, in patients. Conclusion: The trial drug was Highly Significant in all the considered biochemical investigative parameters (Lipid Profile). Thus it can be concluded that orally Triphaladi Ghana Vati can be used as safe and main „Therapeutic Agent‟ in the management of Dyslipidemia.

Keywords: Dosha, Agni, Dhatu, Mala, Medoroga, Dushya, Kapha.